section_path: History/2022
section_name: 2022
paragraph_text: 2022
  
  On 1 January, Europe passed 100 million cases amidst a surge in the Omicron variant. Later that month, the WHO recommended the rheumatoid arthritis drug Baricitinib for severe or critical patients. It also recommended the monoclonal antibody Sotrovimab in patients with non-severe disease, but only those who are at highest risk of hospitalisation.
  
  On 24 January, the Institute for Health Metrics and Evaluation estimated that about 57% of the world's population had been infected by COVID-19. By 6 March, it was reported that the total worldwide death count had surpassed 6 million people. By 6 July, Omicron subvariants BA.4 and BA.5 had spread worldwide. WHO Director-General Tedros Ghebreyesus stated on 14 September 2022, that " never been in a better position to end the pandemic", citing the lowest number of weekly reported deaths since March 2020. He continued, "We are not there yet. But the end is in sight—we can see the finish line".
  
  On 21 October, the United States surpassed 99 million cases of COVID-19, the most cases of any country. By 30 October, the worldwide daily death toll was 424, the lowest since 385 deaths were reported on 12 March 2020. 17 November marked the three-year anniversary since health officials in China first detected COVID-19.
  
  On 11 November, the WHO reported that deaths since the month of February had dropped 90 per cent. Director-General Tedros said this was "cause for optimism". On 3 December, the WHO indicated that, "at least 90% of the world's population has some level of immunity to Sars-CoV-2". In early December, China began lifting some of its most stringent lockdown measures. Subsequent data from China's health authorities revealed that 248 million people, nearly 18 per cent of its population, had been infected in the first 20 days of that month. On 29 December, the US joined Italy, Japan, Taiwan and India in requiring negative COVID-19 test results from all people travelling from China due to the new surge in cases. The EU refused similar measures, stating that the BF7 omicron variant had already spread throughout Europe without becoming dominant.